脊柱转移瘤再程立体定向体部放疗的多机构结局分析
这项多机构汇总分析纳入7家机构215例患者的247个脊柱靶区,评估常规外照射后再程脊柱立体定向体部放疗(SBRT)的影像学局部控制。6个月和12个月总生存率分别为64%和48%,局部控制率分别为93%和83%;无放射性脊髓病发生,椎体压缩骨折率为4.5%。
要点
- 再程脊柱SBRT的6个月和12个月影像学局部控制率分别为93%和83%。
- 6个月和12个月总生存率分别为64%和48%。
- 单次SBRT是多变量分析中局部控制更好的显著预测因素。
核心结论
- 再程脊柱SBRT能有效获得影像学局部控制,安全性在临床可接受范围内。
- 作者认为需要随机试验来确定最佳分割方案。
研究设计与样本
- 多机构汇总分析,7家机构共215例患者、247个脊柱靶区。
- 总生存按患者计算,局部控制按治疗的脊柱靶区计算,均采用Kaplan-Meier法。
- 局部控制定义为SBRT靶区内影像学进展。
- 采用α/β=10(肿瘤)和α/β=2(脊髓和马尾)计算常规外照射和SBRT的2 Gy分次等效剂量(EQD2)。
主要发现
- 初始常规外照射中位总剂量/分次数为30 Gy/10次。
- SBRT中位总剂量为18 Gy、中位分次数为1次。
- 60%的脊柱靶区接受单次SBRT(中位16.6 Gy,EQD2/10=36.8 Gy),40%接受多次SBRT(中位24 Gy/3次,EQD2/10=36 Gy)。
- 从常规外照射到再程SBRT的中位时间间隔为13.5个月,患者中位随访时间为8.1个月。
- 13%的患者出现局部失败;6个月和12个月局部控制率分别为93%和83%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE This study is a multi-institutional pooled analysis specific to imaging-based local control of spinal metastases in patients previously treated with conventional external beam radiation therapy (cEBRT) and then treated with re-irradiation stereotactic body radiotherapy (SBRT) to the spine as salvage therapy, the largest such study to date. METHODS The authors reviewed cases involving 215 patients with 247 spinal target volumes treated at 7 institutions. Overall survival was calculated on a patient basis, while local control was calculated based on the spinal target volume treated, both using the Kaplan-Meier method. Local control was defined as imaging-based progression within the SBRT target volume. Equivalent dose in 2-Gy fractions (EQD2) was calculated for the cEBRT and SBRT course using an α/β of 10 for tumor and 2 for both spinal cord and cauda equina. RESULTS The median total dose/number of fractions of the initial cEBRT was 30 Gy/10. The median SBRT total dose and number of fractions were 18 Gy and 1, respectively. Sixty percent of spinal target volumes were treated with single-fraction SBRT (median, 16.6 Gy and EQD2/10 = 36.8 Gy), and 40% with multiple-fraction SBRT (median 24 Gy in 3 fractions, EQD2/10 = 36 Gy). The median time interval from cEBRT to re-irradiation SBRT was 13.5 months, and the median duration of patient follow-up was 8.1 months. Kaplan-Meier estimates of 6- and 12-month overall survival rates were 64% and 48%, respectively; 13% of patients suffered a local failure, and the 6- and 12-month local control rates were 93% and 83%, respectively. Multivariate analysis identified Karnofsky Performance Status (KPS) < 70 as a significant prognostic factor for worse overall survival, and single-fraction SBRT as a significant predictive factor for better local control. There were no cases of radiation myelopathy, and the vertebral compression fracture rate was 4.5%. CONCLUSIONS Re-irradiation spine SBRT is effective in yielding imaging-based local control with a clinically acceptable safety profile. A randomized trial would be required to determine the optimal fractionation.
引用
- Hashmi A, Guckenberger M, Kersh R, et al. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis. J Neurosurg Spine. 2016. PMID: 27341054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。